Predictions
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€45.02
08.02.24
08.02.24
-
08.02.25
08.02.25
2.13%
12:02
12:02
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€36.29
22.11.23
22.11.23
€47.00
31.08.24
31.08.24
3.34%
12:04
12:04
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€55.30
17.11.23
17.11.23
-
17.11.26
17.11.26
-6.96%
10:30
10:30
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€48.00
24.10.23
24.10.23
€55.00
05.07.24
05.07.24
7.19%
10:30
10:30
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€32.44
26.09.23
26.09.23
-
26.09.24
26.09.24
41.74%
12:02
12:02
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€32.44
26.09.23
26.09.23
-
26.09.24
26.09.24
41.74%
12:02
12:02
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€48.33
27.07.23
27.07.23
€57.00
27.07.24
27.07.24
-22.50%
12:04
12:04
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Innovative
High dividend yield expected
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€45.95
13.07.23
13.07.23
-
13.07.24
13.07.24
-18.49%
12:04
12:04
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€57.50
06.03.23
06.03.23
€70.00
06.03.25
06.03.25
-19.17%
12:02
12:02
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€57.50
06.03.23
06.03.23
€70.00
06.03.25
06.03.25
-19.17%
12:02
12:02
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€48.92
25.04.22
25.04.22
€120.00
03.02.25
03.02.25
-4.99%
12:02
12:02
Higher EBIT margin than peer group
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€48.92
25.04.22
25.04.22
€120.00
03.02.25
03.02.25
-4.99%
12:02
12:02
Higher EBIT margin than peer group
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation